Your browser doesn't support javascript.
Ventilator associated pneumonia in COVID-19 patients: A retrospective cohort study.
Ferliçolak, Leyla; Saricaoglu, Elif Mukime; Bilbay, Burak; Altintas, Neriman Defne; Yörük, Fügen.
  • Ferliçolak L; Division of Intensive Care, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
  • Saricaoglu EM; Department of Infection Diseases and Clinical Microbiology, Ankara University Faculty of Medicine, Ankara, Türkiye.
  • Bilbay B; Deparment of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
  • Altintas ND; Division of Intensive Care, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
  • Yörük F; Department of Infection Diseases and Clinical Microbiology, Ankara University Faculty of Medicine, Ankara, Türkiye.
Tuberk Toraks ; 71(1): 41-47, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2258999
ABSTRACT

Introduction:

We aimed to evaluate ventilator-associated pneumonia (VAP) incidence rate, risk factors, and isolated microorganisms in COVID-19 patients as the primary endpoint. Evaluation of VAP-associated intensive care unit (ICU) and hospital mortalities was the secondary endpoint. Materials and

Methods:

Records of patients admitted between March 2020- June 2021 to our pandemic ICU were reviewed and COVID-19 patients with VAP and non-VAP were evaluated retrospectively. Comorbidities, management, length of ICU stay, and outcomes of VAP and non-VAP patients, as well as risk factors for VAP mortality, were identified.

Result:

During the study period, 254 patients were admitted to the ICU. After the exclusion, the data of 208 patients were reviewed. In total, 121 patients required invasive mechanical ventilation, with 78 (64.5%) developing VAP. Length of ICU and hospital stays were longer in VAP patients (p<0.01 and p<0.01 respectively). Steroid use was higher in VAP patients, although it was not statistically significant (p= 0.06). APACHE II score (p<0.01) was higher in non-VAP patients. ICU mortality was high in both groups (VAP 70%, non-VAP 77%). VAP mortality was higher in males (p= 0.03) and in patients who required renal replacement therapy (p= 0.01). Length of ICU stay (p= 0.04), and length of hospital stay (p<0.01) were both high in VAP survivors. The most common isolated microorganisms were Acinetobacter spp. and Klebsiella spp. in VAP patients and most of them were extensively drug-resistant.

Conclusions:

Critically ill COVID-19 patients who required invasive mechanical ventilation developed VAP frequently. The length of ICU stay was longer in patients who developed VAP and ICU mortality was high in both VAP and non-VAP patients. The length of hospital and ICU stays among VAP survivors were also considerably high which is probably related to the long recovery period of COVID-19. The most frequently isolated microorganisms were Acinetobacter spp. and Klebsiella spp. in VAP patients.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Ventilator-Associated / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Male Language: English Journal: Tuberk Toraks Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Ventilator-Associated / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans / Male Language: English Journal: Tuberk Toraks Year: 2023 Document Type: Article